Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma

Overview of attention for article published in Scientific Reports, September 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 5 X users, with an upper bound of 5,602 followers.

@rule_simon Small series but older also seem to do well with cytarabine. https://t.co/qwIk2P9f4E

26 Oct 2019

Reply Repost Favourite

@HenrychihangFu1 @graham74GC Cytarabine based induction is also good in older patients with mantle cell lymphoma but HyperCVAD is too toxic. https://t.co/qwIk2P9f4E

26 Oct 2019

Reply Repost Favourite

RT @OpatStephen: Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma | Sc…

02 Oct 2019

Reply Repost Favourite

Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma | Scientific Reports. Congrats Josh & Sumi https://t.co/qwIk2P9f4E

01 Oct 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.